Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Novartis AG logo
NOVN.SW
Novartis AG
13:12:18
119 Fr
0.0000 (%0.00)
Previous Close: 118.04
Day Low₺118.42
Day High₺119.96
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

NOVN.SW: Novartis AG Financials

Novartis AG Income Statement

Total revenue
Net income
Gross margin TTM
75.02%
Operating margin TTM
31.15%
Net profit margin TTM
25.64%
Return on investment TTM
31.78%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue57,126,379,00051,722,000,00046,660,000,00043,461,000,000
Operating income17,795,162,00014,544,000,0009,769,000,0007,946,000,000
Net income14,649,294,00011,941,000,00014,850,000,0006,955,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue57,126,379,00051,722,000,00046,660,000,00043,461,000,000
Cost of revenue14,267,976,00012,827,000,00012,472,000,00011,582,000,000
Gross profit42,858,402,00038,895,000,00034,188,000,00031,879,000,000
Research and development expenses11,195,438,00010,022,000,00011,371,000,0009,172,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses13,867,802,00012,566,000,00012,517,000,00012,193,000,000
Other expenses01,763,000,000531,000,0002,568,000,000
Operating expenses25,063,240,00024,351,000,00024,419,000,00023,933,000,000
Cost and expenses39,331,216,00037,178,000,00036,891,000,00035,515,000,000
Net interest income-846,441,000-454,782,000-258,358,000-470,889,000
Interest income390,746,000550,781,000658,499,000389,310,000
Interest expense1,237,186,0001,005,564,000916,857,000860,199,000
Depreciation and amortization5,578,339,0006,069,000,0008,277,000,0006,705,000,000
EBITDA23,958,048,00020,715,000,00018,255,000,00014,682,000,000
EBIT18,379,709,00014,646,000,0009,978,000,0007,977,000,000
Non-operating income (excl. interest)-584,547,000-102,000,000-209,000,000-31,000,000
Operating income17,795,162,00014,544,000,0009,769,000,0007,946,000,000
Total other income/expenses (net)-665,210,000-904,000,000-646,000,000-769,000,000
Income before tax17,129,952,00013,640,000,0009,123,000,0007,177,000,000
Income tax expense2,498,467,0001,701,000,000551,000,0001,128,000,000
Net income from continuing operations14,631,485,00011,939,000,0008,572,000,0006,049,000,000
Net income from discontinued operations006,282,000,000906,000,000
Other adjustments to net income0000
Net income14,649,294,00011,941,000,00014,850,000,0006,955,000,000
Net income deductions0000
Bottom line net income14,649,294,00011,941,000,00014,850,000,0006,955,000,000
EPS8673
Diluted EPS7673
Weighted average shares outstanding1,938,950,0002,018,000,0002,089,756,0972,181,180,341
Weighted average diluted shares outstanding1,955,000,0002,035,000,0002,092,000,0002,197,000,000

Novartis AG Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
29,572,592,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets115,493,204,000102,246,000,00099,945,000,000117,453,000,000
Total liabilities68,974,733,00058,120,000,00053,195,000,00058,030,000,000
Total equity46,099,746,00044,046,000,00046,667,000,00059,342,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents11,427,500,00011,459,000,00013,393,000,0007,517,000,000
Short-term investments154,898,0001,892,000,000569,000,00011,098,000,000
Cash and short-term investments11,582,399,00013,351,000,00013,962,000,00018,615,000,000
Net receivables10,926,829,0009,539,000,0009,376,000,0009,894,000,000
Accounts receivable8,931,139,0007,423,000,0007,107,000,0008,066,000,000
Other receivables1,995,690,0002,116,000,0002,269,000,0001,828,000,000
Inventory6,264,888,0005,723,000,0005,913,000,0007,175,000,000
Prepaid expenses1,152,244,000985,000,000764,000,000911,000,000
Other current assets513,663,000106,000,000466,000,000315,000,000
Total current assets30,440,023,00029,704,000,00030,481,000,00036,910,000,000
Property, plant and equipment (net)12,343,899,00010,873,000,00010,924,000,00012,195,000,000
Goodwill25,550,232,00024,756,000,00023,341,000,00029,301,000,000
Intangible assets29,391,711,00026,915,000,00026,879,000,00031,644,000,000
Goodwill and intangible assets54,941,943,00051,671,000,00050,220,000,00060,945,000,000
Long-term investments2,302,489,0001,128,000,0001,827,000,0001,606,000,000
Tax assets10,051,403,0004,359,000,0004,309,000,0003,739,000,000
Other non-current assets5,413,447,0004,511,000,0002,184,000,0002,058,000,000
Total non-current assets85,053,181,00072,542,000,00069,464,000,00080,543,000,000
Other assets0000
Total assets115,493,204,000102,246,000,00099,945,000,000117,453,000,000
Total payables6,420,786,0007,676,000,0008,155,000,0009,258,000,000
Accounts payable4,453,078,0004,572,000,0004,926,000,0005,146,000,000
Other payables1,967,709,0003,104,000,0003,229,000,0004,112,000,000
Accrued expenses2,480,000,0002,169,000,0001,986,000,0001,942,000,000
Short-term debt5,521,000,0008,089,000,0006,084,000,0005,876,000,000
Capital lease obligations (current)263,000,000235,000,000230,000,000251,000,000
Tax payables02,225,000,0002,409,000,0002,533,000,000
Deferred revenue0127,000,00098,000,000123,000,000
Other current liabilities12,546,593,00010,396,000,0009,837,000,00011,206,000,000
Total current liabilities27,260,110,00028,692,000,00026,390,000,00028,656,000,000
Long-term debt29,572,592,00021,366,000,00018,436,000,00020,244,000,000
Capital lease obligations (non-current)1,655,913,0001,568,000,0001,598,000,0001,538,000,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)8,011,742,0002,419,000,0002,248,000,0002,686,000,000
Other non-current liabilities2,474,376,0004,075,000,0004,523,000,0004,906,000,000
Total non-current liabilities41,714,624,00029,428,000,00026,805,000,00029,374,000,000
Other liabilities0000
Capital lease obligations1,918,913,0001,803,000,0001,828,000,0001,789,000,000
Total liabilities68,974,733,00058,120,000,00053,195,000,00058,030,000,000
Treasury stock-49,967,000-53,000,000-41,000,000-92,000,000
Preferred stock0000
Common stock765,498,000793,000,000825,000,000890,000,000
Retained earnings44,690,670,00046,561,000,00049,649,000,00063,540,000,000
Additional paid-in capital0000
Accumulated other comprehensive income/loss693,545,000-3,248,014,000-3,704,316,000-4,997,799,000
Other stockholders' equity0000
Total stockholders' equity46,099,746,00044,046,000,00046,667,000,00059,342,000,000
Total equity46,518,471,00044,126,000,00046,750,000,00059,423,000,000
Minority interest418,725,00080,000,00083,000,00081,000,000
Total liabilities and total equity115,493,204,000102,246,000,00099,945,000,000117,453,000,000
Total investments2,457,387,0003,020,000,0002,396,000,00012,704,000,000
Total debt37,008,712,00031,258,000,00026,348,000,00027,909,000,000
Net debt25,581,212,00019,799,000,00012,955,000,00020,392,000,000

Novartis AG Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations20,054,782,00017,619,000,00014,458,000,00014,236,000,000
Cash from investing-5,109,025,000-7,513,000,0005,596,000,0001,468,000,000
Cash from financing-15,574,303,000-11,742,000,000-14,278,000,000-20,562,000,000
Net change in cash-1,671,784,000-1,934,000,0005,876,000,000-4,890,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income14,649,294,00011,939,000,0008,572,000,0006,955,000,000
Depreciation and amortization5,578,339,0006,069,000,0008,277,000,0007,181,000,000
Deferred income tax-377,127,0001,701,000,000551,000,0001,416,000,000
Stock-based compensation01,044,000,000865,000,000791,000,000
Change in working capital-3,205,581,000-706,000,000-369,000,000-1,003,000,000
Accounts receivable-1,177,475,000-931,000,000-1,504,000,000-589,000,000
Inventory35,618,000-225,000,000-546,000,000-830,000,000
Accounts payable-285,988,000-105,000,000479,000,000-48,000,000
Other working capital-1,777,735,000555,000,0001,202,000,000464,000,000
Other non-cash items3,409,857,000-2,428,000,000-3,438,000,000-1,104,000,000
Net cash from operating activities20,054,782,00017,619,000,00014,458,000,00014,236,000,000
Investments in property, plant and equipment-4,085,544,000-1,366,000,000-1,060,000,000-2,671,000,000
Acquisitions (net)-3,133,298,000-3,921,000,000-3,561,000,000-903,000,000
Purchases of investments-317,415,000-3,648,000,000-747,000,000-34,816,000,000
Sales/maturities of investments2,280,572,0003,701,000,00011,596,000,00039,490,000,000
Other investing activities146,660,000-2,279,000,000-632,000,000368,000,000
Net cash from investing activities-5,109,025,000-7,513,000,0005,596,000,0001,468,000,000
Net debt issuance2,839,977,0004,390,000,000-1,935,000,000-2,837,000,000
Long-term net debt issuance2,834,739,0005,881,000,000-258,000,000-2,837,000,000
Short-term net debt issuance5,238,000-1,491,000,000-1,677,000,0000
Net stock issuance-9,621,980,000-8,331,000,000-8,719,000,000-10,652,000,000
Net common stock issuance-9,621,980,000-8,331,000,000-8,719,000,000-10,652,000,000
Common stock issuance28,285,000000
Common stock repurchased-9,650,264,000-8,331,000,000-8,719,000,000-10,652,000,000
Net preferred stock issuance0000
Net dividends paid-8,189,944,000-7,624,000,000-7,255,000,000-7,506,000,000
Common dividends paid-8,189,944,000-7,624,000,000-7,255,000,000-7,506,000,000
Preferred dividends paid0000
Other financing activities-602,356,000-177,000,0003,631,000,000433,000,000
Net cash from financing activities-15,574,303,000-11,742,000,000-14,278,000,000-20,562,000,000
Effect of FX changes on cash-1,043,239,000-298,000,000100,000,000-32,000,000
Net change in cash-1,671,784,000-1,934,000,0005,876,000,000-4,890,000,000
Cash at end of period11,427,500,00011,459,000,00013,393,000,0007,517,000,000
Cash at beginning of period13,099,284,00013,393,000,0007,517,000,00012,407,000,000
Operating cash flow20,054,782,00017,619,000,00014,458,000,00014,236,000,000
Capital expenditure-1,621,647,000-3,814,000,000-2,753,000,000-2,671,000,000
Free cash flow18,433,136,00013,805,000,00011,705,000,00011,565,000,000
Income taxes paid0000
Interest paid0000